Anneke M Westermann (Anneke Westermann)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Locally Advanced

Endometrial Cancer

Randomized Controlled Trial

Top Venues

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Acta oncologica (Stockholm, Sweden)

Clinical cancer research : an official journal of the American Association for Cancer Research

This page only lists publications with an associated author ORCID identifier.

Publications

Anneke M Westermann, Petronella Ottevanger, An Reyners, Judith R Kroep, Martijn G H Van Oijen, Roy I Lalisang, Petronella O Witteveen
PAZEC: a Dutch Gynaecological Oncology Group open-label, multicenter, phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 34 (2) (2024)
Anneke M Westermann, Petronella Ottevanger, An Reyners, Judith R Kroep, Martijn G H Van Oijen, Roy I Lalisang, Petronella O Witteveen
PAZEC: a Dutch Gynaecological Oncology Group open-label, multicenter, phase II study of pazopanib in metastatic and locally advanced hormone-resistant endometrial cancer. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
Rachel N Grisham, Ignace Vergote, Susana Banerjee, Esther Drill, Elsa Kalbacher, Mansoor Raza Mirza, Ignacio Romero, Peter Vuylsteke, Robert L Coleman, Felix Hilpert, Amit M Oza, Anneke M Westermann, Martin K Oehler, Sandro Pignata, Carol Aghajanian, Nicoletta Colombo, David Cibula, Kathleen M Moore, Josep M Del Campo, Regina Berger, Christian Marth, Jalid Sehouli, David M O'Malley, Cristina Churruca, Gunnar B Kristensen, Andrew R Clamp, John Farley, Gopakumar V Iyer, Isabelle L Ray-Coquard, Bradley J Monk
Molecular Results and Potential Biomarkers Identified from the Phase 3 MILO/ENGOT-ov11 Study of Binimetinib vs Physician Choice of Chemotherapy in Recurrent Low-Grade Serous Ovarian Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Ignace Vergote, Els Van Nieuwenhuysen, Roisin E O'Cearbhaill, Anneke M Westermann, Domenica Lorusso, Sharad Ghamande, Dearbhaile C Collins, Susana Banerjee, Cara A Mathews, Christine Gennigens, David Cibula, Krishnansu S Tewari, Kristine Madsen, Fatih Köse, Amanda L Jackson, Ingrid A Boere, Giovanni Scambia, Leslie M Randall, Azmat Sadozye, Jean-François Baurain, Eelke H Gort, Michal Zikán, Hannelore G Denys, Petronella B Ottevanger, Frédéric Forget, Camilla Mondrup Andreassen, Lamar Eaton, Michael J Chisamore, Leonardo Viana Nicacio, Ibrahima Soumaoro, Bradley J Monk
Tisotumab Vedotin in Combination With Carboplatin, Pembrolizumab, or Bevacizumab in Recurrent or Metastatic Cervical Cancer: Results From the innovaTV 205/GOG-3024/ENGOT-cx8 Study. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Daphne Schouten, Rob van Os, Anneke M Westermann, Johannes Crezee, Geertjan van Tienhoven, M Willemijn Kolff, Adriaan D Bins
A randomized phase-II study of reirradiation and hyperthermia versus reirradiation and hyperthermia plus chemotherapy for locally recurrent breast cancer in previously irradiated area. Acta oncologica (Stockholm, Sweden) 61 (4) (2022)